Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Brain energy metabolism changes and neuropsychological impairment in Parkinson disease vs Alzheimer disease.
Bi-compartmental CSF-serum analysis of NfL and GFAP differentiates central and peripheral pathology in neuroinfectious diseases: A monocentric real-world cohort study.
Determinants of relapse risk under disease-modifying therapies in multiple sclerosis: an Andersen-Gill Cox regression analysis.
Obinutuzumab β for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial.
FLAMES presenting as refractory focal status epilepticus: Diagnostic clues in MOG antibody-associated cortical encephalitis.
AQP4-IgG-positive myelitis occurring in a patient with small cell lung cancer: a case report.
Anti-Contactin-1 Nodopathy Presenting With Dysphagia and Nephrotic Syndrome: Remarkable Neurological and Renal Recovery Following Early B-Cell-Targeted Therapy.
Delayed Genetic Diagnosis of a Rare Presentation of Overlapping Peripheral Myelin Protein 22 (PMP22) Neuropathies.
A tolerogenic mRNA-LNP vaccine alleviates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis.
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.
Demyelinating disorders in women: epidemiology, immunology, and clinical implications across MS, NMOSD, and MOGAD.
Predictors of prognosis in children under six years of age with recurrent croup: a retrospective cohort study.
E-based physical exercise in patients with multiple sclerosis and comorbidity (COMPACT): feasibility study and protocol for a randomized controlled trial.
Refining neuropsychological assessment strategies in multiple sclerosis: insights from long-term cognitive trajectories.
Home Monitoring of Visual Functions in Neuro-Ophthalmic Diseases Using an AI-Assisted Virtual Reality Platform.
Preservation of positive emotion recognition in patients with multiple sclerosis: Artefact related to methodological issues or real feature of the disorder?
Comparative Analysis of Mouse CSF Proteins in Experimental Autoimmune Encephalomyelitis Model and Cuprizone-Induced Demyelination Model by Olink Proteomics.
Association between choroid plexus enlargement and impaired glymphatic function in relapsing-remitting multiple sclerosis.
EBV reactivation priming of the peripheral immune system in multiple sclerosis relapse.
Dissociating Fatigue and Fatigability in Multiple Sclerosis: The Role of Cognitive Processing Speed.
Diagnosing multiple sclerosis: implementation and unintended effects of the 2024 McDonald criteria.
Early Inpatient Rehabilitation Following Neuromyelitis Optica Spectrum Disorder Flare: A Case Report.
Remogliflozin Attenuates Cyclophosphamide- Associated Peripheral Neurotoxicity in Rats: Concomitant Changes in Redox, Inflammatory, Neurotrophic, and Apoptosis-Related Markers.
Assessing Unmet Social Needs in Multiple Sclerosis Care in Australia: A Qualitative Assessment of Feasibility, Barriers and Enablers.
Rethinking prognosis in multiple sclerosis: a multiaxial perspective.
Pages
« first
‹ previous
…
1034
1035
1036
1037
1038
1039
1040
1041
1042
…
next ›
last »